beta-lactams has been researched along with Clostridioides difficile Infection in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 14 (73.68) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Axelrod, P; Holaday, E; Mishkin, A; Motzer, AR | 1 |
| Hong, JJ; Hwang, EH; Jeong, KJ; Kang, P; Kim, G; Koo, BS; Lee, HY; Lim, KS; Mo, I; Oh, H; Park, JY; Villinger, F | 1 |
| Afra, K; Lee, C; Mina, N; Saad, S | 1 |
| Branch-Elliman, W; Gupta, K; Itani, KMF; O'Brien, WJ; Perencevich, E; Ripollone, JE; Schweizer, ML; Strymish, J | 1 |
| Buscher, H; Gentili, S; Imani, S; Marriott, D; Sandaradura, I | 1 |
| Al-Hasan, MN; Bookstaver, PB; Dash, S; Haggard, E; Justo, JA; Kohn, J; Mediwala, KN; Rac, H; Seddon, MM | 1 |
| Boerlin, P; Mehdizadeh Gohari, I; Prescott, JF | 1 |
| Goldenberg, SD | 1 |
| Coughlin, O; Kokai-Kun, JF; Le, C; Roberts, T; Sliman, J; Stevenson, R; Wacher, VJ; Whalen, H | 1 |
| Bush, K; Pucci, MJ | 1 |
| dos Santos, VM; Ferrer, M; Friedrichs, AK; Heinsen, FA; Knecht, C; Knecht, H; Neulinger, SC; Ott, SJ; Rosenstiel, PC; Schilhabel, A; Schmitz, RA; Schreiber, S; Zimmermann, A | 1 |
| Barrantes, G; Molina, J; Quesada-Gómez, C; Rodríguez, C; Rodríguez-Cavallini, E | 1 |
| Baudin, G; Bouvet, P; Cua, E; Degand, N; Lotte, L; Lotte, R; Popoff, MR; Roger, PM; Ruimy, R | 1 |
| Garritson, S; Lee, S; Lin, M; Liu, C; Nichols, A; Prasad, P | 1 |
| Park, M; Rafii, F | 1 |
| Balada-Llasat, JM; Buckosh, M; Hemminger, J; Pancholi, P; Raczkowski, M | 1 |
| Casas, CO; Fernández, FM; Guilera, ED; Guillen, VV; Salido, AJ; Tarragó, AC | 1 |
| Abramson, MA; Awad, SS; Finn, TS; Itani, KM; Jensen, EH; Wilson, SE | 1 |
| Debrueres, J; Deronzier, M; Roudon, T; Sedallian, A | 1 |
1 review(s) available for beta-lactams and Clostridioides difficile Infection
| Article | Year |
|---|---|
Investigational antimicrobial agents of 2013.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactams; Clinical Trials as Topic; Clostridium Infections; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drugs, Investigational; Gram-Negative Bacteria; Gram-Positive Bacteria; Health Surveys; Humans; Molecular Mimicry; Protein Synthesis Inhibitors; Topoisomerase Inhibitors; Tuberculosis | 2013 |
2 trial(s) available for beta-lactams and Clostridioides difficile Infection
| Article | Year |
|---|---|
Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Female; Humans; Incidence; Male; Middle Aged; Recombinant Proteins; Respiratory Tract Infections; Treatment Outcome | 2019 |
Ertapenem versus cefotetan prophylaxis in elective colorectal surgery.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefotetan; Clostridioides difficile; Clostridium Infections; Colorectal Surgery; Double-Blind Method; Elective Surgical Procedures; Ertapenem; Female; Humans; Infusions, Intravenous; Logistic Models; Male; Middle Aged; Prospective Studies; Risk Factors; Surgical Wound Infection; Treatment Failure | 2006 |
16 other study(ies) available for beta-lactams and Clostridioides difficile Infection
| Article | Year |
|---|---|
Effects of reported beta-lactam allergies on pneumonia outcomes in lung transplant recipients.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Clostridium Infections; Drug Hypersensitivity; Fluoroquinolones; Humans; Hypersensitivity; Lung; Pneumonia; Retrospective Studies; Transplant Recipients | 2022 |
Prevalence and characterization of Clostridium perfringens isolated from feces of captive cynomolgus monkeys (Macaca fascicularis).
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; beta-Lactams; Biofilms; Clostridium Infections; Clostridium perfringens; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Feces; Female; Genotype; Macaca fascicularis; Male; Phylogeny; Prevalence; RNA, Ribosomal, 16S | 2020 |
Oral beta-lactam step down in bacteremic E. coli urinary tract infections.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Blood Culture; Clostridioides difficile; Clostridium Infections; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Length of Stay; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Urinary Tract Infections | 2020 |
Risk of surgical site infection, acute kidney injury, and Clostridium difficile infection following antibiotic prophylaxis with vancomycin plus a beta-lactam versus either drug alone: A national propensity-score-adjusted retrospective cohort study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Clostridioides difficile; Clostridium Infections; Cohort Studies; Drug Combinations; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Surgical Wound Infection; United States; United States Department of Veterans Affairs; Vancomycin | 2017 |
Too much of a good thing: a retrospective study of β-lactam concentration-toxicity relationships.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clostridium Infections; Cohort Studies; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Floxacillin; Humans; Incidence; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Neurotoxicity Syndromes; Piperacillin; Retrospective Studies; Thienamycins | 2017 |
Role of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection Following Enterobacteriaceae Bloodstream Infections.
Topics: Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; beta-Lactams; Clostridioides difficile; Clostridium Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Risk Factors; South Carolina; Time Factors | 2019 |
Antimicrobial Susceptibility and Clonal Relationship of Tetracycline Resistance Genes in
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Canada; Clostridium Infections; Clostridium perfringens; DNA, Bacterial; Dogs; Horses; Multilocus Sequence Typing; Switzerland; Tetracycline; Tetracycline Resistance; United States | 2019 |
A solution to the problem of antibiotic induced collateral damage to the gut microbiome.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Clostridium Infections; Double-Blind Method; Gastrointestinal Microbiome; Humans; Recombinant Proteins | 2019 |
Effects of β-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea.
Topics: Ampicillin; beta-Lactams; Cephalosporins; Clostridioides difficile; Clostridium Infections; Diarrhea; Fluoroquinolones; Gastrointestinal Tract; Humans; Microbiota; RNA, Ribosomal, 16S; Sulbactam | 2014 |
Phenotypic and genotypic characterization of multidrug-resistant Bacteroides, Parabacteroides spp., and Pseudoflavonifractor from a Costa Rican hospital.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides Infections; beta-Lactamases; beta-Lactams; Clindamycin; Clostridium; Clostridium Infections; Costa Rica; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Genotype; Humans; Metronidazole; Mutation; Phenotype | 2014 |
Lumbar discitis caused by Clostridium perfringens.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Clindamycin; Clostridium Infections; Clostridium perfringens; Discitis; Female; Genotype; Humans; Intervertebral Disc Degeneration; Intervertebral Disc Displacement; Microbial Sensitivity Tests; Polymerase Chain Reaction; Spine; Tomography, X-Ray Computed | 2014 |
Ertapenem Prophylaxis Associated With an Increased Risk of Clostridium difficile Infection Among Surgical Patients.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Cross Infection; Ertapenem; Female; Hospitalization; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Postoperative Complications; Retrospective Studies; Risk Factors | 2015 |
Exposure to β-lactams results in the alteration of penicillin-binding proteins in Clostridium perfringens.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cattle; Chickens; Clostridium Infections; Clostridium perfringens; DNA Mutational Analysis; Mutation, Missense; Penicillin-Binding Proteins; Selection, Genetic | 2017 |
Two case reports of Clostridium difficile bacteremia, one with the epidemic NAP-1 strain.
Topics: Adult; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Clostridioides difficile; Clostridium Infections; Comorbidity; Humans; Male; Ohio; Treatment Outcome; Vancomycin | 2011 |
Spontaneous abscess of the anterior abdominal wall caused by Clostridium perfringens resistant to clindamycin.
Topics: Abdominal Abscess; Abdominal Pain; Abdominal Wall; Aged; Anti-Bacterial Agents; beta-Lactams; Clindamycin; Clostridium Infections; Clostridium perfringens; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Soft Tissue Infections; Tomography, X-Ray Computed | 2012 |
[In vitro activity of beta-lactams, clindamycin and metronidazole on Clostridium difficile].
Topics: Anti-Bacterial Agents; beta-Lactams; Clindamycin; Clostridium; Clostridium Infections; Humans; In Vitro Techniques; Metronidazole; Microbial Sensitivity Tests | 1988 |